Rosiglitazone versus placebo for men with prostate carcinoma and a rising serum prostate-specific antigen level after radical prostatectomy and/or radiation therapy

Cancer ◽  
2004 ◽  
Vol 101 (7) ◽  
pp. 1569-1574 ◽  
Author(s):  
Matthew R. Smith ◽  
Judith Manola ◽  
Donald S. Kaufman ◽  
Daniel George ◽  
William K. Oh ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document